Passage bio inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The average passage bio stock price prediction forecasts a potential downside of n/a from the current pasg share price of $7.51.
Data shows that the passage bio inc.
Passage bio stock forecast. Traders who pay close attention to intraday price movement should know that it fluctuated between. Their forecasts range from $2.21 to $45.00. Earnings for passage bio are expected to grow in the coming year.
Share is performing relatively much not better than most of its peers within the same. Investorsobserver gives passage bio inc (pasg) an overall rank of 47, which is below average. Passage bio granted an option to purchase 130,000 shares of common stock to this employee as a material inducement to employment in accordance with nasdaq listing rule 5635(c)(4).
Passage bio has generated ($3.38) earnings per share over the last year ( ($3.38) diluted earnings per share). (nasdaq:mbio) closed higher on monday, november 01, closing at $2.38, 6.25% higher than its previous close. Passage bio last issued its earnings results on november 4th, 2021.
The trading price of mustang bio inc. On average, they anticipate passage bio's stock price to reach $27.03 in the next year. Bionano genomics stock was originally listed at a price of $6.15 in aug 21, 2018.
Passage bio's share price could stay at $31.50 by jul 1, 2022. The average price target represents a 230.12% change from the last price of $7.27. On average, wall street analysts predict that.
Based on 3 wall street analysts offering 12 month price targets for passage bio in the last 3 months. The reported ($0.87) eps for the quarter, missing analysts' consensus estimates of ($0.80) by $0.07. (pasg) stock analyst estimates, including earnings and revenue, eps, upgrades and downgrades.
A rank of 47 means that 53% of stocks appear more favorable to our system. Bxrx) could pass $2.00 in one year stock forecast. The average price target is $24.00 with a high forecast of $25.00 and a low forecast of $23.00.
This suggests a possible upside of 265.2% from the stock's current price. Blnk | complete blink charging co. Pasg) revealed in a filing with the sec, richard morris, its chief financial officer, will leave the company, effective may 30, to pursue other opportunities.
View analysts' price targets for passage bio or.
